These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18670163)

  • 41. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
    Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
    Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QT interval correction assessment in the anesthetized guinea pig.
    Morissette P; Regan HK; Fitzgerald K; Bernasconi S; Gerenser P; Travis J; Fanelli P; Sannajust F; Regan CP
    J Pharmacol Toxicol Methods; 2015; 75():52-61. PubMed ID: 26001325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of QT interval using a linear model in individual cynomolgus monkeys.
    Koga T; Kuwano K; Kito G; Kanefuji K
    J Pharmacol Toxicol Methods; 2007; 55(3):248-53. PubMed ID: 17141531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of intravenous propranolol on QT interval. A new method of assessment.
    Milne JR; Camm AJ; Ward DE; Spurrell RA
    Br Heart J; 1980 Jan; 43(1):1-6. PubMed ID: 7356855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QT interval correction for drug-induced changes in body temperature during integrated cardiovascular safety assessment in regulatory toxicology studies in dogs: A case study.
    El Amrani AI; El Amrani-Callens F; Loriot S; Singh P; Forster R
    J Pharmacol Toxicol Methods; 2016; 81():136-43. PubMed ID: 27095299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval.
    Indik JH; Pearson EC; Fried K; Woosley RL
    Heart Rhythm; 2006 Sep; 3(9):1003-7. PubMed ID: 16945790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of QT(c)-prolonging potential of BX471 in healthy volunteers. A 'thorough QT study' following ICH E14 using various QT(c) correction methods.
    Vandemeulebroecke M; Lembcke J; Wiesinger H; Sittner W; Lindemann S
    Br J Clin Pharmacol; 2009 Sep; 68(3):435-46. PubMed ID: 19740402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour Holter recordings.
    Molnar J; Weiss J; Zhang F; Rosenthal JE
    Am J Cardiol; 1996 Oct; 78(8):920-6. PubMed ID: 8888666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heart.
    Qu Y; Fang M; Gao B; Chui RW; Vargas HM
    J Pharmacol Exp Ther; 2011 Apr; 337(1):2-8. PubMed ID: 21205913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic beat-to-beat modeling of the QT-RR interval relationship: analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition.
    Fossa AA; Wisialowski T; Magnano A; Wolfgang E; Winslow R; Gorczyca W; Crimin K; Raunig DL
    J Pharmacol Exp Ther; 2005 Jan; 312(1):1-11. PubMed ID: 15306635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical analysis of QT interval as a function of changes in RR interval in the conscious dog.
    Raunig D; Depasquale MJ; Huang CH; Winslow R; Fossa AA
    J Pharmacol Toxicol Methods; 2001; 46(1):1-11. PubMed ID: 12164254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autonomic tone attenuates drug-induced QT prolongation.
    Smith AH; Norris KJ; Roden DM; Kannankeril PJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):960-4. PubMed ID: 17666066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys.
    Holzgrefe HH; Cavero I; Gleason CR; Warner WA; Buchanan LV; Gill MW; Burkett DE; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(2):159-75. PubMed ID: 16857392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The heart rate-corrected QT interval of conscious beagle dogs: a formula based on analysis of covariance.
    Spence S; Soper K; Hoe CM; Coleman J
    Toxicol Sci; 1998 Oct; 45(2):247-58. PubMed ID: 9848132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ciprofloxacin does not Prolong the QTc Interval: A Clinical Study in ICU Patients and Review of the Literature.
    Heemskerk C; Woldman E; Pereboom M; Van der Hoeven R; Mantel-Teeuwisse A; Van Gemeren C; Becker ML
    J Pharm Pharm Sci; 2017; 20(1):360-364. PubMed ID: 29145929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval.
    Gress KL; Gallo T; Urits I; Geng X; Viswanath O; Kaye AD; Woosley RL
    Cureus; 2020 Aug; 12(8):e9668. PubMed ID: 32923263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The risk of treatment-induced QT interval prolongation.
    Chaverri-Fernández JM; Díaz-Madriz JP; Zavaleta-Monestel E; Cordero-García E; Fallas-Mora A; Escalona-Rodríguez R
    Farm Hosp; 2022 Mar; 46(3):116-120. PubMed ID: 36183204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monophasic action potential in anaesthetized guinea pigs as a biomarker for prediction of liability for drug-induced delayed ventricular repolarization.
    Tabo M; Kimura K; Ito S
    J Pharmacol Toxicol Methods; 2007; 55(3):254-61. PubMed ID: 17229580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.